Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
4 studies found for:    16407512 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL
Condition: Acute Lymphoblastic Leukemia (ALL)
Intervention: Drug: Allopurinol
2 Completed Intensified Conditioning Regimen With High-Dose-Etoposide for Allo-HSCT for Adult Acute Lymphoblastic Leukemia
Conditions: Acute Lymphoblastic Leukemia;   Stem Cell Transplantation, Hematopoietic
Interventions: Drug: TBI/CY/VP-16;   Drug: FA-TBI/CY/VP-16
3 Terminated Total Therapy Study XIV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Prednisone, Dexamethasone, Vincristine, Daunorubicin, PEG-L-asparaginase;   Drug: L-asparaginase, Methotrexate, Idarubicin, Etoposide, Cyclophosphamide, Cytarabine, Mercaptopurine
4 Active, not recruiting
Has Results
Therapy for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia
Condition: Lymphoblastic Leukemia, Acute
Interventions: Drug: Prednisone, Dexamethasone, Vincristine, Daunorubicin;   Drug: Doxorubicin, L-asparaginase, PEG-L-asparaginase, Erwinia asparaginase;   Drug: Methotrexate, Cyclophosphamide, Cytarabine, Etoposide;   Drug: Mercaptopurine, Imatinib;   Procedure: chemotherapy, intrathecal chemotherapy;   Procedure: steroid therapy, hematopoietic stem cell transplantation

Study has passed its completion date and status has not been verified in more than two years.